730 likes | 1.18k Views
Organ Sparing Treatments for Early Rectal Cancer The Oregon Gut Club. Mark H. Whiteford, MD, FACS, FASCRS Director, Colon and Rectal Surgery | Providence Cancer Center Clinical Associate Professor | Oregon Health & Science University
E N D
Organ Sparing Treatments for EarlyRectal Cancer The Oregon Gut Club Mark H. Whiteford, MD, FACS, FASCRS Director, Colon and Rectal Surgery | Providence Cancer Center Clinical Associate Professor | Oregon Health & Science University Gastrointestinal and Minimally Invasive Surgery Division | The Oregon Clinic, PC
Disclosure • Richard Wolf Medical Instruments • Research funding • Consultant
Rectal Cancer • Colorectal Cancer is second most common cause of cancer related death in the US • Rectal cancer accounts for 40% of these • 36,400 new cases (56% male) • 8,600 deaths (55% male)
Advancements in Rectal Cancer Treatment • Improved tumor imaging: • Endoscopic ultrasound • Rectal MRI
Advancements in Rectal Cancer Treatment • Improved tumor imaging: • Endoscopic ultrasound • Rectal MRI • Advantages of neoadjuvantchemoradiation • Stage 2 and 3
Advancements in Rectal Cancer Treatment • Improved tumor imaging: • Endoscopic ultrasound • Rectal MRI • Advantages of neoadjuvantchemoradiation • Stage 2 and 3 • Better understanding of surgical technique: • 1-2 cm distal margin = Sphincter sparing techniques • Total mesorectal excision
Total Mesorectal Excision • Established gold standard for radical excision of rectal cancer • Nerve sparing technique • Lower local recurrence rates • Improved survival
What is a rectum? • Anus to … • 15 cm? • Upper rectal fold? • “Rectosigmoid junction”? • Peritoneal reflection? • Top of S3?
Gordon PH, 2nd Ed, 1999 The Anatomic Rectum 15 cm Anal Verge
Gordon PH, 2nd Ed, 1999 The Oncologic Rectum 15 cm 12 cm Anal Verge NCI Guidelines 2000 for Colon and Rectal Cancer Surgery, JNCI 2001
Clinical Evaluation • History • Family history • Continence history • Evaluation of operative risk • Physical • Abdomen • Digital Rectal Examination • Rigid proctoscopy
Rectal Cancer Work Up • Clearing colonoscopy • CBC • CMP • CEA • CT Scan Abdomen / Pelvis • Chest imaging (CXR or CT) • Endoscopic Ultrasound (MRI)
The early rectal cancer dilemma • Stage 1 rectal cancer is a curable disease with radical surgery But…
The early rectal cancer dilemmaThe cost for cure • Total mesorectal excision associated with • Long hospital stay and convalescence • Infectious complications • Urinary dysfunction • Sexual dysfunction • Defecatory dysfunction • Some need permanent ostomy
Bowel DysfunctionRadical surgery for rectal cancer Temple et al, DCR 2005
Sexual DysfunctionRadical surgery for rectal cancer Activity: Pre Op Post Op Loss Spont Embarrassed APR 91% 55% 53% 44% LAR 94% 74% 27% 24% TAE 80% 87% 13% 0% Hendren et al, Ann Surg 2005
Full Thickness Local Excision • “Total Biopsy” • Thorough histologic evaluation • Polyp vs Cancer? • Tumor differentiation • Depth of invasion • Completeness of excision
Local Excision is Appealing • Low morbidity • Quick recovery • Minimal effect on long term bowel function • Organ sparing technique
Local Excision: In an Ideal World • If … • we know that there is no tumor in the lymph nodes • and technically a FTLE can be done, • the surgery should be curative! • And if there is a recurrence … • we can always perform salvage surgery!
Predicting success? • How to predict which tumors are confined to the rectal wall ? • What tumor characteristics predict node positivity?
Local Treatment of Rectal CancerT-stage relates to Lymph Node Metastasis Morson BC Proc R Soc Med 1966 Hojo K Am J Surg 1982 Minsky BD Cancer 1989 Huddy SPJ BJS 1993 T1 10.9% 17.9% 0% 11% T2 12.1% 37.8% 28% 23% T3 58.3% >50% 36% ns
Favorable Features of Early Rectal Cancers • T1 • Moderate to well differentiated • Negative margins • No LVI • < 4cm greatest dimension • < 40% circumference • < 8-10 cm from anal verge
Case series of FTLE Morson, et al. GUT 1977
CALGB 8984 Trial • Full Thickness Local Excision Steele, et al, Ann Surg Oncol 1999
CALGB 8984 Trial Steele, et al, Ann Surg Oncol 1999
Local Treatments for Rectal Cancer • Transanal excision of rectal neoplasmsbecame standard practice:
Unfortunately . . . the oncologic results have been disappointing
Favorable T1 CancersParks Trans Anal Excision (TAE) Mellgren (2000) n=TAE 69 OS 30 Paty (2002) n=TAE 74 Nascimbeni (2004) n=TAE 70 OS 74 Madbouly (2005) n=52 Local Recurrence TAE 18%Rsxn 4% (TME) TAE 14% TAE 7%Rsxn 3% (TME) TAE 17% Survival (CSS/Overall) TAE 72%Rsxn80% TAE 92% TAE 89%(72%)Rsxn90% TAE 89%(75%) “Transanal excision equals total mesorectal neglect” - David Rothenberger
Salvage Surgery for Recurrence FTLE • Recurrent stages (n=29) • stage 1: 2 • stage 2: 13 • stage 3: 12 • stage 4: 2 • Mean time to recurrence = 26 months • 23/29 underwent curative surgery • Mean follow up = 39 months Friel, et al. Dis Colon Rectum 2002
Salvage Surgery for Recurrence FTLE Patients DFS Overall 29 12(59%) T1 10 7(70%) T2 19 10(53%) Good histol 22 15(68%) Bad histol 7 2(29%) Friel, et al. Dis Colon Rectum 2002
Salvage Surgery for Recurrence FTLE • 49/50 patients underwent curative surgery • 31 Abdomioperineal • 11 Low anterior • 4 Pelvic exenteration • 1 Transanal excision • 27 (55%) multivisceral resections • 47/49 underwent R0 resection Weiser, et al. Dis Colon Rectum 2005
Salvage Surgery for Recurrence FTLE 5 year Survival 53% Weiser, et al. Dis Colon Rectum 2005
Why the high failure rates? • Progression of occult lymphatic tumor • Implantation of viable tumor cells • Better histologic predictors • Remove deeper en bloc section of mesorectum • More precise instrumentation • Less traumatic tissue handling • Better visualization
Better Histologic Predictors • Routine use of EUS • Submucosal Depth of Invasion Kikuchi Classification: 1-3% 8-10% 23-25% • Eventually: molecular markers
Why the high failure rates? • Progression of occult lymphatic tumor • Implantation of viable tumor cells • Better histologic predictors • Remove deeper en bloc section of mesorectum • More precise instrumentation • Less traumatic tissue handling • Better visualization
Origins of TEM Standard transanal excision: • Limited to lesions: • distal rectum • small tumors (<3 cm) • However… • lighting and exposure is poor • surgical field collapses “short reach, poor visibility”
Origins of TEM Professor Gerhard Buess
Transanal Endoscopic Microsurgery 4 cm x 10-20 cm proctoscope, airtight faceplate, insufflation, telescope, and laparoscopic instruments
Other requirements for TEM • Need correct equipment • Need staff familiar with equipment • Need a surgeon skilled in TEM
Where can TEM help? • Progression of occult lymphatic tumor • Implantation of viable tumor cells • Better histologic predictors • Remove deeper en bloc section of mesorectum • More precise instrumentation • Less traumatic tissue handling • Better visualization